Top Headlines

iBio, GE partner to work on plant-based production tech

iBio, CMB and GE Healthcare are collaborating on developing and marketing biopharm production systems, including plant-based expression technology.

News in brief

Bend receives patent for making spray-dried drug dispersions using pressure nozzles

US formulation services provider Bend Research has received a new patent for the process of producing spray-dried solid amorphous dispersions of drugs using single-fluid pressure nozzles.

BI opens ‘Centre of Competence’ opens as part of a €100m China plan

Boehringer Ingelheim has opened its ‘Centre of Competence’ (CoC) in Shanghai to optimise API and chemical intermediates sourcing in China.

Ranbaxy opens $30m SA plant to meet govt call for India trade boost

Ranbaxy is latest firm targeting South African growth with a new £30m (€24m) Johannesburg tablet and capsule manufacturing plant.

NanGenex adds bench-top, pilot nano API production tech

NanGenex is introducing GMP bench-top and pilot plant reactors to scale-up its process for the continuous production of nanostructured active ingredients.

Today's headlines across the Pharmaceutical industry

Accenture & ICRI partner for Indian clinical research training from Outsourcing-Pharma.com

Accenture and ICRI have partnered to jointly develop a pharmacovigilance and clinical research programme for the Indian market.

Quintiles lands CF drug commercialisation contract from Outsourcing-Pharma.com

Quintiles will help Australian drugmaker Pharmaxis launch its cystic fibrosis treatment Bronchitol in Europe under a contract announced yesterday.

Asuragen adds KRAS, BRAF testing for personalised med from Outsourcing-Pharma.com

Asuragen is introducing KRAS and BRAF mutational testing services to support development of personalised colorectal cancer treatments.

TiGenix to spin-out drug discovery activities as Arcarios from Outsourcing-Pharma.com

TiGenix to spin-out its discovery and development business as new small-molecule focused industry-academia consortium Arcarios.

On your radar